No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
434 |
4. Check minimum number of eventsNone |
434 |
5. Include endpointsNone |
434 |
6. Filter based on genotype QC (FinnGen only) |
434 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF7
Hypertrophy of tongue papillae
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2799 | 1597 | 1191 |
| Only index persons | 2669 | 1527 | 1142 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.05 | 0.03 |
| Only index persons | 0.05 | 0.06 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 55.06 | 55.67 | 54.28 |
| Only index persons | 55.73 | 56.39 | 54.85 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 434 | 263 | 171 |
| Unadjusted period prevalence (%) | 0.08 | 0.09 | 0.08 |
| Median age at first event (years) | 59.84 | 58.23 | 62.31 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 375
- Matched controls
- 3748
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K14.31
ICD-10 Finland
Coated tongue
+∞
143.1
128
*
K14.30
ICD-10 Finland
Black hairy tongue
+∞
134.7
121
*
K14.39
ICD-10 Finland
Papillary hypertrophy of the tongue UNS
+∞
68.9
64
*
K14.38
ICD-10 Finland
Other papillary hypertrophy of the tongue
+∞
36.0
34
*
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
19.0
28.7
44
26
K14.3
ICD-10 Finland
Hypertrophy of tongue papillae
+∞
25.3
24
*
SAA02
NOMESCO Finland
Basic examination of mouth
2.8
17.9
282
1946
A07AA02
ATC
nystatin; oral
5.2
16.7
54
118
A01AB09
ATC
miconazole; local oral
4.1
14.5
60
168
D20
ICPC
Mouth/tongue/lip symptom/complaint
5.8
14.1
40
75
SAA01
NOMESCO Finland
Simple examination of mouth
2.5
13.6
289
2148
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.3
13.2
184
1105
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
2.2
12.5
207
1336
SAA03
NOMESCO Finland
Extended examination of mouth
2.2
12.4
175
1052
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.3
12.0
150
846
K02.1
ICD-10 Finland
Caries of dentine
2.2
11.7
234
1628
SFA10
NOMESCO Finland
Fillning on one surface of tooth
2.2
11.6
225
1540
K02.8
ICD-10 Finland
Other dental caries
7.9
10.8
24
32
K02.0
ICD-10 Finland
Caries limited to enamel
2.9
10.7
69
271
WX110
NOMESCO Finland
Local anesthesy
2.2
10.2
278
2139
Z01.2
ICD-10 Finland
Dental examination
2.1
10.2
176
1126
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
3.3
9.9
51
171
B37.0
ICD-10 Finland
Candidal stomatitis
9.5
9.6
19
21
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
3.0
9.5
57
210
SDA02
NOMESCO Finland
Parodonthologic therapy
2.1
9.5
145
872
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
22.4
9.4
13
6
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
2.0
9.0
231
1686
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
2.0
9.0
155
975
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
2.3
8.9
93
470
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.9
8.8
221
1598
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.9
8.8
195
1346
K14.1
ICD-10 Finland
Geographic tongue
20.6
8.5
12
6
J02AC01
ATC
fluconazole; systemic
2.0
8.5
158
1016
K14.32
ICD-10 Finland
Hypertrophy of papillae foliatae
+∞
8.4
8
*
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.9
8.3
176
1186
WZA90
NOMESCO Finland
Other doctors statement
2.2
8.3
100
540
A02BC05
ATC
esomeprazole; systemic
1.9
7.8
158
1044
R52.9
ICD-10 Finland
Pain, unspecified
3.1
7.7
43
151
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.0
7.7
119
707
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
7.7
121
728
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
18.8
7.6
11
6
C05AA08
ATC
fluocortolone; rectal, topical
2.5
7.5
62
277
D82
ICPC
Teeth/gum disease
1.9
7.4
138
878
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
6.0
7.3
19
33
SPAT1263
SPAT
Sampling
1.8
7.3
172
1187
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
5.0
7.3
22
46
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.8
7.0
159
1079
S18
ICPC
Laceration/cut
1.8
6.8
163
1123
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.9
6.8
114
695
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
6.7
139
911
SPAT1312
SPAT
General health counselling
1.9
6.7
124
785
SBA00
NOMESCO Finland
Microbiological examinations
6.4
6.5
16
26
A01AB04
ATC
amphotericin B; local oral
3.5
6.5
29
88
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
6.4
91
520
H02AB06
ATC
prednisolone; systemic
1.7
6.4
177
1270
N02BE01
ATC
paracetamol; systemic, rectal
2.0
6.2
318
2752
WX290
NOMESCO Finland
Other blockade of nerve
1.7
6.2
166
1175
K03.66
ICD-10 Finland
Tooth plaque
3.0
6.2
35
126
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
6.1
164
1159
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.3
6.1
54
252
SPAT1310
SPAT
Counselling related to known health issue
1.8
6.1
123
794
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026389) Candida sp identified in Specimen by Organism specific culture
33
39
9.08
26.09
1.3
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
99
453
2.54
13.55
1.8
1.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
344
2660
2.41
12.67
5.2
4.0
mm/h
13.4
11.7
1.09
318
2446
(3024561) Albumin [Mass/volume] in Serum or Plasma
217
1452
1.99
11.10
5.8
4.5
g/l
36.2
35.8
0.49
200
1365
(3013115) Eosinophils [#/volume] in Blood
257
1855
1.95
10.21
7.3
5.7
e9/l
0.2
0.2
0.26
228
1657
(42870588) Differential panel, method unspecified - Blood
181
1171
1.94
9.91
7.1
5.4
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
241
1719
1.90
9.75
7.7
5.7
%
27.2
28.2
0.73
225
1619
(3018010) Neutrophils/100 leukocytes in Blood
238
1696
1.89
9.60
7.5
5.5
%
58.3
57.1
0.75
224
1607
(3019198) Lymphocytes [#/volume] in Blood
253
1845
1.89
9.43
6.9
5.5
e9/l
1.8
2.0
0.84
224
1652
(3006315) Basophils [#/volume] in Blood
249
1807
1.89
9.42
7.0
5.4
e9/l
0.0
0.0
0.50
220
1584
(3013826) Glucose [Moles/volume] in Serum or Plasma
275
2061
1.91
9.41
5.1
4.8
mmol/l
6.5
6.7
0.73
261
1910
(3006504) Eosinophils/100 leukocytes in Blood
234
1671
1.87
9.25
7.8
5.6
%
2.7
2.8
0.19
216
1569
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
340
2748
2.10
9.22
9.6
7.4
u/l
78.9
76.9
0.41
328
2578
(3001604) Monocytes [#/volume] in Blood
246
1798
1.85
8.90
6.8
5.4
e9/l
0.6
0.6
1.85
218
1574
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
56
237
2.56
8.85
1.9
1.4
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
233
1679
1.84
8.78
8.2
5.8
%
8.6
8.5
0.09
217
1591
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
253
1870
1.85
8.78
6.8
6.3
umol/l
10.8
11.0
0.04
242
1775
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
163
1051
1.88
8.78
2.7
2.1
u/l
168.8
245.2
0.50
153
988
(3022096) Basophils/100 leukocytes in Blood
226
1614
1.84
8.77
8.0
5.6
%
0.6
0.7
0.44
209
1518
(3032080) INR in Blood by Coagulation assay
198
1372
1.81
8.36
7.1
8.3
inr
1.2
1.2
0.28
56
415
(3048689) Calprotectin [Mass/mass] in Stool
86
450
2.14
8.35
2.2
2.1
ug/g
206.1
117.5
0.45
65
354
(3037467) Urinalysis macro (dipstick) panel - Urine
312
2485
1.91
8.31
5.4
4.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
168
1125
1.80
7.82
3.6
2.4
u/l
56.2
56.3
0.02
157
1046
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
230
1702
1.75
7.48
9.3
6.7
mmol/l
1.2
1.2
0.01
190
1439
(3015377) Calcium [Moles/volume] in Serum or Plasma
174
1190
1.77
7.46
4.3
3.3
mmol/l
2.4
2.4
0.01
142
1048
(40768804) Tissue Pathology biopsy report
202
1445
1.74
7.38
2.7
2.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
88
488
2.01
7.25
1.3
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
383
3337
2.26
7.13
5.7
4.7
mu/l
1.8
2.3
0.68
354
3068
(3013512) EKG study
154
1029
1.77
7.08
5.0
3.8
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
87
486
1.99
7.01
1.4
1.3
titre
397.3
454.5
0.19
15
113
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
404
3608
2.73
7.01
20.0
13.3
mg/l
20.4
22.4
0.70
343
2830
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
111
677
1.86
6.87
1.8
1.5
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
16
36
4.58
6.76
3.6
1.4
mosm/kgh2o
286.4
283.1
0.21
16
23
(3023368) Bacteria identified in Blood by Culture
138
917
1.74
6.35
4.5
4.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
265
2097
1.68
6.27
11.3
8.9
e9/l
4.3
4.1
1.21
239
1866
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
330
2786
1.77
5.99
4.6
3.9
pmol/l
14.9
14.8
0.19
303
2537
(3012095) Magnesium [Moles/volume] in Serum or Plasma
90
536
1.86
5.93
3.4
3.7
mmol/l
0.8
0.8
0.47
80
512
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
129
857
1.72
5.87
2.2
2.0
mg/l
3.1
3.1
0.06
112
753
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
208
1565
1.63
5.86
7.7
5.8
mmol/l
1.2
1.2
0.42
189
1413
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
88
523
1.86
5.83
2.3
1.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
296
2439
1.67
5.73
3.7
3.0
u/l
47.0
45.3
0.18
274
2289
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
123
814
1.71
5.65
1.3
1.2
u/ml
2.1
1.9
0.03
35
220
(3022145) Colonoscopy Study observation
73
414
1.92
5.57
1.4
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
233
1818
1.61
5.55
4.0
3.6
estimate
0.0
0.0
0.50
52
335
(40758558) Short blood count panel - Blood
133
905
1.68
5.49
7.6
6.6
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
74
427
1.88
5.36
8.6
5.3
mmol/l
1.1
1.0
0.45
67
402
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
182
1353
1.59
5.21
4.6
3.6
ng/l
32.2
38.2
0.31
126
937
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
44
212
2.20
5.21
1.6
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
97
619
1.73
5.02
1.3
1.3
u/ml
3.4
12.8
2.38
36
250
(3005322) IgE [Units/volume] in Serum or Plasma
44
217
2.14
4.92
1.3
1.2
u/ml
259.9
260.1
0.00
35
196
(3035350) Ketones [Presence] in Urine by Test strip
226
1783
1.56
4.91
3.8
3.5
estimate
0.0
0.0
0.00
49
350
(3019309) Folate [Moles/volume] in Red Blood Cells
97
624
1.71
4.87
1.7
1.7
nmol/l
1195.0
1236.0
0.15
73
483
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
192
1465
1.56
4.81
2.9
2.2
nmol/l
78.9
77.1
0.41
170
1309
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
169
1257
1.56
4.72
3.2
3.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
145
1051
1.57
4.49
2.7
3.1
e6/l
270.3
109.4
0.27
120
809
(3021601) Nitrite [Presence] in Urine by Test strip
225
1796
1.52
4.49
5.4
4.8
estimate
0.0
0.0
0.50
54
351
(3007853) Bacteria identified in Skin by Aerobe culture
70
421
1.79
4.42
2.2
1.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
144
1048
1.56
4.36
2.7
2.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
181
1388
1.52
4.31
4.0
3.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
97
645
1.65
4.26
1.4
1.3
iu/ml
37.3
40.6
0.07
23
201
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
136
983
1.56
4.22
2.9
3.2
ng/l
1217.8
1050.3
0.27
108
842
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
106
724
1.61
4.18
1.8
1.7
pmol/l
457.7
443.5
0.23
81
600
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
182
1404
1.51
4.18
2.5
1.9
pmol/l
99.7
96.4
0.46
100
733
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
69
422
1.76
4.12
2.1
2.2
—
—
—
0
0
(3026782) Osmolality of Urine
102
694
1.61
4.08
2.7
2.7
mosm/kgh2o
549.1
561.3
0.18
92
590
(3030467) Casts [#/volume] in Urine by Automated count
133
965
1.55
4.03
2.9
3.0
e6/l
0.3
0.4
0.30
109
722
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
64
386
1.77
4.00
2.1
2.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
16
53
3.10
4.00
1.2
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
209
1672
1.48
3.95
4.5
4.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
107
743
1.58
3.92
1.4
1.4
g/l
2.2
2.4
0.62
57
455
(3000492) Spirometry study
57
335
1.81
3.89
1.5
1.4
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
22
90
2.52
3.78
3.0
2.9
mg/l
1.8
1.5
0.54
22
83
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
27
122
2.29
3.75
2.1
1.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
397
3675
1.94
3.74
21.7
15.4
mmol/l
139.6
139.7
0.25
390
3579
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
367
3324
1.67
3.70
6.3
5.6
mmol/mol
39.7
39.5
0.13
345
3125
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
411
3857
2.24
3.63
13.6
10.1
u/l
26.8
26.4
0.17
402
3725
(3023103) Potassium [Moles/volume] in Serum or Plasma
397
3683
1.91
3.59
21.6
15.5
mmol/l
4.0
4.0
0.20
389
3582
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
86
579
1.61
3.57
2.4
2.7
e6/l
1.0
1.0
0.07
52
332
(3000850) Epithelial cells [#/volume] in Urine
104
733
1.55
3.55
2.3
2.4
e6/l
5.9
5.9
0.02
95
648
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
49
289
1.78
3.31
3.0
2.7
ml/min/173m2
63.0
66.0
0.24
22
127
(3013139) Helicobacter pylori Ag [Presence] in Stool
41
229
1.87
3.30
1.2
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
110
798
1.51
3.26
1.7
1.7
mg/l
1.2
1.2
0.02
78
619
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
91
635
1.55
3.23
2.8
2.9
mmol/l
2.5
2.4
0.38
78
564
(3018095) Leukocytes [#/volume] in Urine
160
1252
1.44
3.23
3.3
3.6
e6/l
44.5
75.5
0.89
128
880
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
380
3505
1.68
3.18
5.2
4.4
mmol/l
5.9
5.9
0.10
346
3227
(3045424) Erythrocytes [Presence] in Urine
16
61
2.69
3.17
2.0
1.3
—
—
—
0
0
(4062490)
11
34
3.29
3.08
1.8
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
132
1007
1.45
3.02
3.4
3.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
14
51
2.80
3.01
1.0
1.1
u/ml
0.8
1.7
—
7
23
(1761482) Bacteria [#/volume] in Urine by Culture
22
101
2.24
2.98
4.2
5.0
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
46
276
1.75
2.95
6.0
4.4
%
0.4
0.4
0.01
16
66
(3025159) Blasts/100 leukocytes in Blood
45
269
1.75
2.92
7.0
4.6
%
0.0
0.1
0.66
17
72
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
23
109
2.17
2.90
1.8
2.1
ug/l
283.8
675.5
0.43
23
102
(40760892) CBC W Ordered Manual Differential panel - Blood
113
845
1.46
2.85
5.6
4.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
117
2.11
2.83
1.7
2.0
g/l
9.7
10.2
0.32
19
105
(3022948) Iron [Moles/volume] in Serum or Plasma
77
533
1.54
2.82
4.0
2.3
umol/l
14.5
13.5
0.21
71
492
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
68
458
1.57
2.81
3.9
2.3
%
24.0
22.7
0.15
60
399
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
111
830
1.45
2.80
2.7
2.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
31
167
1.92
2.80
5.1
3.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
141
1102
1.41
2.79
2.7
2.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
194
1601
1.38
2.79
12.1
9.1
e9/l
0.0
0.0
0.63
168
1328
(3026493) Urate [Moles/volume] in Serum or Plasma
119
903
1.44
2.77
2.5
2.6
umol/l
346.1
6314.1
3.45
96
793
(3007461) Platelets [#/volume] in Blood
421
4033
2.47
2.77
29.5
19.6
e9/l
255.3
251.4
0.58
415
3939
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
26
132
2.03
2.76
3.4
1.9
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
5
6
8.41
2.75
1.0
1.0
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
45
274
1.72
2.75
2.5
2.6
g/l
10.0
10.7
0.57
37
247
(3026361) Erythrocytes [#/volume] in Blood
421
4036
2.44
2.71
29.3
19.5
e12/l
4.5
4.5
1.17
413
3935
(3022217) INR in Platelet poor plasma by Coagulation assay
63
421
1.58
2.69
30.3
19.8
inr
1.1
1.3
—
8
58
(3010813) Leukocytes [#/volume] in Blood
421
4037
2.43
2.69
29.4
19.6
e9/l
7.0
6.7
3.39
414
3936
(3004716) Salmonella sp identified in Stool by Organism specific culture
34
192
1.84
2.67
1.8
1.3
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
74
514
1.53
2.67
1.7
2.1
s
30.2
29.6
0.36
67
501
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
32
3.18
2.66
1.1
1.3
—
—
—
0
0
(3019225) pH of Specimen
52
333
1.64
2.64
6.3
4.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
126
974
1.41
2.64
3.9
3.8
estimate
0.0
0.0
0.80
54
346
(3004588) Protein electrophoresis panel - Serum or Plasma
39
231
1.76
2.63
1.6
2.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
37
216
1.78
2.62
1.4
1.3
—
34.6
—
0
15
(3020891) Body temperature
26
135
1.98
2.61
7.1
4.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
129
2.00
2.56
1.7
2.0
g/l
7.7
7.5
0.16
18
101
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
129
2.00
2.56
1.7
2.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
129
2.00
2.56
1.7
2.0
g/l
3.7
3.8
0.14
16
94
(3018418) pH of Serum or Plasma
134
1054
1.39
2.53
5.6
3.7
ph
7.4
7.4
0.52
25
204
(3044927) Protein electrophoresis panel - Urine
11
39
2.87
2.49
1.1
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
55
363
1.59
2.48
1.9
1.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
63
430
1.54
2.46
1.7
1.6
%
1.6
1.5
0.47
55
376
(3045414) Leukocytes [Presence] in Urine
29
160
1.87
2.46
2.1
1.7
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
61
415
1.55
2.42
6.7
6.7
mmol/l
105.2
104.2
0.98
61
402
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
33
191
1.79
2.41
1.5
1.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
75
534
1.49
2.41
2.3
2.9
e6/l
2.1
2.3
0.10
41
290
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
37
222
1.73
2.40
2.1
1.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
121
943
1.39
2.39
3.0
2.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
367
3409
1.50
2.39
15.8
12.3
ml/min/173m2
82.7
82.4
0.10
317
2793
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
55
367
1.57
2.38
1.8
1.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
37
223
1.72
2.36
6.9
6.5
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
50
327
1.60
2.35
2.9
1.8
nmol/l
367.6
366.3
0.02
45
302
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
22
112
2.02
2.35
3.1
2.0
u/l
276.7
3567.8
—
8
42
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
59
402
1.54
2.33
2.5
2.6
umol/l
6.2
7.6
0.43
50
354
(3002256) Pathology report gross observation
63
436
1.52
2.32
1.3
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
35
209
1.73
2.31
4.9
3.9
mmol/l
1.7
1.9
0.09
29
155
(4010399)
43
272
1.64
2.31
1.3
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
21
107
2.01
2.24
2.2
1.4
ug/g
361.7
309.0
0.46
13
64
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
31
181
1.77
2.22
1.2
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
24
129
1.91
2.21
1.5
1.6
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
51
341
1.56
2.19
8.0
9.2
%
96.3
95.7
0.48
51
330
(3021440) Promyelocytes/100 leukocytes in Blood
44
284
1.61
2.19
8.0
4.5
%
0.1
0.1
0.56
17
84
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
261
2309
1.33
2.18
3.4
3.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
381
3585
1.51
2.13
5.0
4.4
mmol/l
4.6
4.7
0.74
359
3348
(3019230) Fractional oxyhemoglobin in Venous blood
12
49
2.49
2.12
1.4
1.6
%
71.2
60.2
0.87
12
49
(3017181) Myelocytes/100 leukocytes in Blood
46
303
1.58
2.11
7.7
4.4
%
0.7
0.9
0.17
18
94
(40761511) CBC panel - Blood by Automated count
398
3783
1.63
2.10
20.1
12.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
133
1073
1.35
2.09
3.7
3.1
mmol/l
6.9
7.6
1.21
110
895
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
386
3647
1.53
2.06
5.4
4.8
mmol/l
2.7
2.8
0.58
360
3387
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
29
170
1.76
2.06
2.4
2.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
21
111
1.94
2.04
1.4
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
15
70
2.18
2.00
1.3
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
38
243
1.62
1.98
2.4
2.5
—
12.3
—
0
12
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
19
342
0.54
1.95
1.9
1.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
21
113
1.90
1.95
1.4
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
44
293
1.56
1.94
1.2
1.2
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
47
318
1.54
1.93
8.4
9.5
g/l
115.9
122.2
1.09
47
309
(3012516) Albumin [Mass/volume] in Urine
124
1003
1.33
1.90
3.3
3.2
mg/l
1262.7
188.8
0.67
76
637
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
29
175
1.70
1.88
2.1
1.7
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
28
2.89
1.87
1.0
1.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
17
3.56
1.84
1.0
1.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
186
1596
1.29
1.84
3.5
2.7
ug/l
130.6
120.2
0.23
170
1486
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
378
3573
1.45
1.83
4.9
4.3
mmol/l
1.5
1.5
0.56
353
3325
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
51
356
1.49
1.83
4.6
4.6
ug/l
4.8
18.2
0.61
43
303
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
78
591
1.39
1.81
1.4
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
23
3.08
1.80
1.0
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
129
1059
1.31
1.77
4.3
4.0
mg/mmol
7.9
8.4
0.06
82
650
(3021960) Folate [Moles/volume] in Serum or Plasma
105
837
1.34
1.77
1.7
1.5
nmol/l
20.0
21.2
0.35
88
713
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
20
110
1.86
1.76
4.4
2.9
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
99
784
1.34
1.74
4.4
3.8
kg/l
1.0
1.0
0.63
16
112
(3027801) Oxygen [Partial pressure] in Arterial blood
53
377
1.46
1.74
7.8
8.8
kpa
11.9
12.3
0.22
53
367
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
53
377
1.46
1.74
7.8
8.8
kpa
5.1
5.1
0.11
53
366
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
13
61
2.17
1.73
1.5
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
13
61
2.17
1.73
1.5
1.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
13
3.88
1.72
4.4
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
40
269
1.54
1.71
3.0
2.8
e9/l
76.1
71.6
0.41
32
215
(3003396) Base excess in Arterial blood by calculation
53
379
1.45
1.69
7.8
8.8
mmol/l
1.5
1.1
0.28
47
303
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
60
440
1.42
1.68
9.2
6.9
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
61
449
1.42
1.67
4.7
4.4
%
32.6
32.1
0.11
46
302
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
20
112
1.82
1.67
1.5
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
14
69
2.06
1.66
1.4
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
25
2.83
1.65
1.3
1.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
366
3455
1.38
1.65
4.3
3.9
mmol/l
1.3
1.3
0.05
341
3205
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
18
98
1.87
1.64
1.9
2.2
g/l
0.0
0.1
0.49
18
92
(40761535) Cells panel - Urine sediment
43
297
1.50
1.63
3.2
3.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
67
504
1.39
1.63
1.9
2.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
8
32
2.53
1.60
2.5
2.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
36
241
1.54
1.58
2.4
3.5
ng/l
126.2
203.8
1.13
29
217
(3011397) Hemoglobin [Presence] in Urine by Test strip
101
818
1.31
1.52
3.7
3.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
44
312
1.46
1.48
3.2
3.3
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
32
212
1.55
1.48
11.2
9.0
mmol/l
25.3
24.3
0.82
32
200
(3012544) pH of Venous blood
45
321
1.45
1.47
4.1
3.4
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
19
111
1.74
1.41
7.9
3.5
mmol/l
3.8
3.9
0.20
19
101
(3000991) Gas panel - Venous blood
38
265
1.48
1.40
5.9
8.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
7
29
2.44
1.39
1.1
1.2
—
—
—
0
0
(4035726)
43
309
1.43
1.37
1.6
1.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
17
2.96
1.36
1.2
1.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
29
192
1.55
1.36
1.4
2.7
e6/l
0.2
0.2
0.06
29
185
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
116
970
1.27
1.36
1.8
1.6
mmol/l
1.4
1.4
0.28
99
824
(3049717) Cytology report of Urine Cyto stain
21
128
1.67
1.36
2.2
2.8
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
21
128
1.67
1.36
7.1
3.8
mmol/l
1.1
1.4
1.65
21
123
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
18
105
1.75
1.35
1.4
1.2
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
16
90
1.81
1.35
2.0
2.2
g/l
0.0
0.0
0.00
16
85
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
13
232
0.55
1.34
1.8
1.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
39
0.00
1.34
0.0
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
49
363
1.39
1.32
3.5
3.1
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
16
91
1.79
1.30
2.0
2.2
g/l
0.0
0.0
0.00
16
85
(3017732) Neutrophils [#/volume] in Blood
34
236
1.48
1.29
1.8
2.3
e9/l
4.1
4.0
0.06
24
189
(3044889) 12 lead EKG panel
271
2498
1.23
1.26
4.3
3.7
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
8
36
2.24
1.25
1.3
1.2
ug/l
2.5
3.1
—
8
31
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
25
2.42
1.24
1.0
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
9
45
2.02
1.24
1.0
1.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
11
56
1.99
1.23
2.7
2.8
mmol/l
4.1
4.0
0.43
11
56
(3033705) Calcium.ionized [Moles/volume] in Venous blood
11
56
1.99
1.23
2.7
2.8
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
11
56
1.99
1.23
2.7
2.8
mmol/l
104.5
105.8
0.61
11
56
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
37
2.18
1.22
3.0
3.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
37
2.18
1.22
1.1
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
30
206
1.49
1.21
1.5
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
26
2.33
1.19
1.2
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
38
2.13
1.19
4.0
2.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
19
118
1.64
1.17
1.2
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
39
2.07
1.16
1.1
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
20
2.52
1.15
1.0
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
20
2.52
1.15
1.6
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
20
2.52
1.15
1.6
1.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
43
321
1.38
1.13
3.0
2.3
u/l
29.1
29.7
0.09
36
280
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
58
1.92
1.13
1.3
1.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
36
261
1.41
1.12
6.2
3.4
ng/l
98.9
76.7
0.54
30
230
(3027945) Reticulocytes/100 erythrocytes in Blood
49
375
1.35
1.11
3.0
2.7
%
1.9
1.8
0.47
44
346
(40767503) Oxygen content in Capillary blood by calculation
12
66
1.84
1.10
1.5
2.5
%
18.4
15.5
—
5
32
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
21
2.40
1.09
5.8
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
21
2.40
1.09
5.8
1.9
—
—
—
0
0
(3012501) Base excess in Blood by calculation
13
74
1.78
1.08
3.5
2.9
mmol/l
3.3
2.9
—
7
48
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
25
170
1.50
1.07
2.7
2.5
%
1.2
1.2
0.01
25
170
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
78
640
1.27
1.07
4.4
3.8
ng/l
905.7
263.1
0.65
60
496
(46235355) HIV 1 and 2 tests - Meaningful Use set
81
668
1.26
1.07
2.3
1.9
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
19
122
1.58
1.04
1.5
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
117
1008
1.22
1.04
5.3
5.1
ug/l
1.8
2.8
1.33
112
905
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
22
2.29
1.03
5.8
1.8
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
5
22
2.29
1.03
19.0
13.8
nmol/l
1468.4
1713.8
—
5
22
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
5
22
2.29
1.03
15.0
11.4
nmol/l
1230.0
896.6
—
5
22
(3017704) Immunofixation for Urine
5
22
2.29
1.03
1.0
2.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
38
283
1.38
1.02
2.5
2.6
ug/l
3.5
6.8
1.80
31
254
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
9
47
1.93
1.02
1.7
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
10
53
1.91
1.02
1.3
1.6
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
9
48
1.89
1.01
1.0
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
9
48
1.89
1.01
3.0
2.9
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
61
1.82
0.99
1.1
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
16
100
1.62
0.98
1.3
1.2
—
2.7
—
0
16
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
36
1.96
0.97
1.1
1.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
12
69
1.76
0.97
3.4
3.1
%
54.4
57.4
0.36
12
69
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
69
1.76
0.97
1.2
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
15
93
1.63
0.95
1.7
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
15
93
1.63
0.95
1.4
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
52
412
1.30
0.95
2.1
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
14
86
1.65
0.92
3.4
1.7
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
31
228
1.39
0.91
1.5
1.6
g/l
1.0
1.5
1.68
26
208
(3027944) Amphetamines [Presence] in Urine
20
135
1.50
0.91
5.1
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
20
135
1.50
0.91
5.2
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
24
169
1.44
0.89
8.5
12.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
42
1.92
0.89
1.6
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
13
79
1.67
0.89
7.4
2.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
20
136
1.49
0.88
5.2
1.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
11
64
1.74
0.87
1.6
1.3
u/ml
200.6
257.7
—
5
32
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
44
1.83
0.86
4.1
1.9
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
44
1.83
0.86
4.3
1.8
pg
33.0
33.3
—
8
44
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
97
1.57
0.82
1.4
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
32
1.89
0.82
2.3
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
34
260
1.33
0.81
1.1
1.3
iu/ml
185.2
125.4
0.25
13
110
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
17
114
1.51
0.80
2.1
2.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
14
90
1.57
0.79
1.4
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
12
74
1.64
0.79
1.5
5.5
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
13
82
1.60
0.79
1.2
1.2
mmol/l
4.2
3.8
0.89
13
76
(21494890) Protein electrophoresis panel - 24 hour Urine
6
34
1.78
0.76
1.3
2.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
18
124
1.47
0.76
5.6
1.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
33
254
1.32
0.76
2.1
2.2
nmol/l
10.2
12.6
0.65
28
233
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
53
1.71
0.76
1.8
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
54
1.68
0.75
1.3
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
19
133
1.45
0.75
5.4
1.5
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
24
2.10
0.74
1.8
1.6
g/l
1.2
1.0
—
5
24
(21494755) Public health laboratory ask at order entry panel
29
377
0.75
0.74
1.3
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
55
1.65
0.74
1.3
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
55
1.65
0.74
1.3
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
9
55
1.65
0.74
1.3
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
55
1.65
0.74
1.3
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
14
92
1.54
0.73
2.6
2.3
u/ml
0.3
0.4
—
7
47
(4027681)
5
25
2.01
0.73
1.6
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
56
1.62
0.72
1.1
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
56
1.62
0.72
1.3
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
11
68
1.63
0.72
2.3
2.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
40
1.76
0.71
4.4
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
40
1.76
0.71
4.4
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
40
1.76
0.71
4.4
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
26
1.93
0.71
5.8
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
26
1.93
0.71
5.8
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
26
1.93
0.71
5.8
1.8
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
26
1.93
0.71
1.4
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
26
1.93
0.71
5.8
1.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
7
41
1.72
0.70
10.7
3.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
41
1.72
0.70
2.3
2.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
11
69
1.61
0.69
3.1
3.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
25
188
1.35
0.68
4.3
3.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
66
563
1.20
0.67
2.0
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
44
1.60
0.65
1.1
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
30
234
1.30
0.65
4.7
2.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
29
1.73
0.64
1.4
1.8
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
11
71
1.56
0.62
1.9
1.2
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
98
871
1.16
0.62
5.0
3.6
%
94.7
92.2
0.42
92
858
(3032773) Endomysium IgG Ab [Titer] in Serum
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
14
197
0.70
0.60
1.6
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
21
0.00
0.60
0.0
2.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
21
0.00
0.60
0.0
2.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
52
1.55
0.59
1.3
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
16
114
1.42
0.59
1.5
1.3
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
14
97
1.46
0.59
1.4
4.7
—
2.4
—
0
13
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
64
1.58
0.59
3.6
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
15
106
1.43
0.58
6.5
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
35
1.72
0.58
1.2
1.7
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
6
35
1.72
0.58
1.0
1.2
—
94.4
—
0
5
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
13
90
1.46
0.56
3.0
1.7
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
18
133
1.37
0.56
6.1
8.5
%
1.8
1.6
0.32
18
127
(3024891) Influenza virus A+B Ag [Presence] in Specimen
14
99
1.43
0.54
1.2
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
60
1.51
0.54
1.8
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
17
125
1.37
0.54
2.9
3.3
g/l
0.2
0.1
—
8
46
(3003694) ABO and Rh group [Type] in Blood
112
1016
1.14
0.54
1.5
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
11
74
1.50
0.54
2.7
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
10
66
1.53
0.53
1.4
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
9
65
1.39
0.51
1.7
3.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
10
67
1.50
0.50
3.4
2.8
e9/l
3.9
4.4
—
10
67
(40768443) Skin Pathology biopsy report
19
145
1.32
0.49
1.1
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
7
45
1.56
0.49
1.4
2.5
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
315
3049
1.12
0.47
22.6
16.2
%
13.8
13.6
1.28
308
3007
(3019832) Treponema pallidum Ab [Presence] in Serum
43
367
1.19
0.46
2.0
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
50
1.41
0.45
1.0
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
51
1.38
0.44
1.3
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
8
56
1.44
0.42
1.5
1.6
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
16
123
1.31
0.41
1.4
1.4
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
17
132
1.30
0.41
6.4
8.7
%
0.9
0.9
0.05
17
127
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
43
372
1.17
0.40
1.6
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
87
793
1.12
0.40
4.7
4.4
%
19.8
20.6
0.19
43
379
(3009542) Hematocrit [Volume Fraction] of Blood
340
3317
1.12
0.40
20.1
13.9
%
38.8
40.1
1.38
223
2438
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
35
1.43
0.39
1.2
1.7
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
12
89
1.36
0.38
1.0
1.2
—
—
—
0
0
(4146454)
5
37
1.36
0.37
1.8
2.7
—
—
—
0
0
(3039000) Anion gap in Blood
9
70
1.29
0.37
9.8
13.1
mmol/l
10.9
11.4
—
9
65
(3018572) Chloride [Moles/volume] in Blood
9
70
1.29
0.37
9.8
13.1
mmol/l
106.6
106.2
—
9
65
(3045142) Bone marrow Pathology biopsy report
6
43
1.40
0.35
1.3
1.2
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
21
172
1.23
0.35
8.0
9.9
mmol/l
24.8
24.6
0.09
21
161
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
82
1.35
0.34
1.5
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
6
46
1.31
0.33
1.7
1.8
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
54
1.30
0.30
1.1
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
124
1313
0.92
0.30
3.5
2.8
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
57
1.23
0.29
1.6
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
8
66
1.22
0.27
1.7
3.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
12
95
1.27
0.26
1.6
1.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
9
73
1.24
0.25
1.1
1.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
30
264
1.15
0.25
1.5
1.4
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
9
75
1.20
0.25
5.9
3.6
u/ml
18.8
27.9
—
9
75
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
11
87
1.27
0.24
1.9
1.7
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
81
0.74
0.24
1.5
1.5
—
—
—
0
0
(1002224) Polysomnography panel
13
158
0.82
0.24
1.1
1.1
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
38
1.32
0.23
2.4
2.0
%
12.4
13.2
—
5
38
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
38
1.32
0.23
1.6
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
11
88
1.26
0.22
1.4
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
11
88
1.26
0.22
1.4
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
11
88
1.26
0.22
1.4
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
11
88
1.26
0.22
1.4
1.5
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
40
1.25
0.22
1.2
1.1
—
—
—
0
0
(44806118)
5
41
1.22
0.22
1.2
1.6
—
—
—
0
0
(44790049)
5
41
1.22
0.22
1.2
1.6
—
—
—
0
0
(44790047)
5
41
1.22
0.22
1.2
1.6
—
—
—
0
0
(44790048)
5
41
1.22
0.22
1.2
1.6
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
10
0.00
0.21
0.0
5.5
—
40.4
—
0
10
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
22.2
—
0
10
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
13
0.00
0.21
0.0
1.2
—
410.1
—
0
7
(3052851) Hemolysis interference index of Serum or Plasma
13
108
1.21
0.20
3.4
3.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
14
0.00
0.20
0.0
3.8
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
14
0.00
0.20
0.0
3.8
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
9
113
0.79
0.20
1.7
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
44
404
1.10
0.20
1.7
1.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
12
144
0.83
0.20
1.1
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
49
1.23
0.20
1.3
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
49
1.23
0.20
1.8
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
50
1.20
0.20
1.8
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
7
58
1.21
0.18
12.4
1.8
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
11
91
1.21
0.17
1.3
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
80
1.13
0.15
1.7
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
9
83
1.09
0.14
2.8
2.0
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
10
84
1.19
0.14
1.6
3.3
kpa
7.5
7.9
—
10
76
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
11
95
1.16
0.11
1.5
1.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
47
1.06
0.09
1.2
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
48
1.04
0.09
1.2
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
64
0.78
0.08
1.4
1.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
65
0.77
0.08
2.4
1.9
—
—
—
0
0
(4094501)
11
98
1.13
0.07
1.3
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
70
0.86
0.07
1.2
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
13
142
0.91
0.06
1.1
2.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
9
104
0.86
0.06
1.6
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
18
168
1.07
0.06
1.6
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
60
584
1.03
0.05
3.1
3.0
ug/l
0.6
0.8
1.52
48
379
(3047181) Lactate [Moles/volume] in Blood
10
95
1.05
0.00
9.4
11.5
mmol/l
1.5
1.3
—
10
87
(4034850)
13
125
1.04
0.00
7.2
10.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
11
106
1.04
0.00
1.5
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
66
0.91
0.00
1.7
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
60
1.00
0.00
1.3
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
6
0.00
0.00
0.0
7.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
76
0.92
0.00
1.6
1.5
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
6
0.00
0.00
0.0
3.7
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.4
—
57.5
—
0
5
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
9
0.00
0.00
0.0
8.3
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
5.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
9
97
0.93
0.00
1.9
1.2
u/l
11.5
10.8
—
9
81
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
76
0.92
0.00
1.6
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
79
0.88
0.00
1.7
1.6
—
—
—
0
0
(3024471) HLA-A [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
5
56
0.89
0.00
1.2
1.2
—
2.8
—
0
18
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
64
0.94
0.00
1.2
1.8
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
86
0.93
0.00
1.5
1.9
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
6.1
—
0
6
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(4133840)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
60
1.00
0.00
1.3
1.1
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
8
0.00
0.00
0.0
2.4
—
1.3
—
0
8
Mortality – FinRegistry
↥Association
Association between endpoint K11_HYPERTROPHY_TONGUE_PAPILLAE and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| K11_HYPERTROPHY_TONGUE_PAPILLAE | 1.156 [0.89, 1.5] | 0.272 |
| Birth year | 0.998 [0.99, 1.01] | 0.573 |
During the follow-up period (1.1.1998 — 31.12.2019), 117 out of 1269 females with K11_HYPERTROPHY_TONGUE_PAPILLAE died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| K11_HYPERTROPHY_TONGUE_PAPILLAE | 1.423 [1.07, 1.89] | 0.014 |
| Birth year | 0.988 [0.98, 1.0] | 0.011 |
During the follow-up period (1.1.1998 — 31.12.2019), 126 out of 937 males with K11_HYPERTROPHY_TONGUE_PAPILLAE died.
Mortality risk
Mortality risk for people of age
years, who have K11_HYPERTROPHY_TONGUE_PAPILLAE.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.14% | 0.29% |
| 5 | 0.731% | 1.595% |
| 10 | 1.941% | 4.474% |
| 15 | 3.717% | 8.043% |
| 20 | 6.267% | 13.1% |
Relationships between endpoints
↥Index endpoint: K11_HYPERTROPHY_TONGUE_PAPILLAE – Hypertrophy of tongue papillae
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data